期刊文献+

高效液相色谱串联质谱法测定血清非结合雌三醇的前处理研究 被引量:2

Investigate the pretreat conditions of the determination of unconjugated estriol in human serum using high performance liquid chromatography tandem mass spectrometry
下载PDF
导出
摘要 目的优化高效液相色谱串联质谱法(LC-MS/MS)测定血清游离雌三醇(uE3)的前处理方法。方法以活性炭吸附血清为研究基质,通过加入已知量的雌三醇(E3)标准品及E3-2-3-4-13 C3内标,在LC-20AD XR高效液相色谱系统和API 5500串联四级杆质谱仪上对E3检测的色谱条件、质谱条件及萃取条件等进行优化。结果色谱条件:选用菲罗门Knietex色谱柱(100.0mm×2.1mm,2.6μm);有机相为甲醇,水相为0.1mmol/L氟化铵水溶液,8min梯度洗脱。质谱条件:选用电喷雾(ESI)负离子模式和多反应监测(MRM)模式分析,选择质荷比(m/z)287→m/z 145作为E3的定量离子对,m/z 287→m/z 171作为定性监测离子对;选择m/z 290→m/z 148作为内标的定量离子对,m/z 290→m/z 174作为定性监测的离子对。萃取条件:萃取剂为正己烷/乙酸乙酯(50/50,v/v),样品与萃取剂的比例为1∶2,萃取率可达85.71%。结论 E3检测的色谱条件、质谱条件、萃取条件已得到全面优化,为后续建立LC-MS/MS测定人血中uE3的参考方法打下良好基础。 Objective To optimize the pretreat conditions of the determination of unconjugated estriol(uE3)in human serum using isotope dilution liquid chromatography/tandem mass spectrometry(ID-LC-MS/MS).MethodsEstriol(purity99.3% )and estriol-2-3-4-13 C3 were the standard and the internal standard respectively.Activated carbon adsorption serum was used for the study of serum matrix.The liquid chromatography(LC)and mass spectrometry(MS)condition were optimized to increase the sensitivity of the detection by use of the the AB/Sciex API 5500 tandem mass spectrometer equipped with Shimadzu LC-20 AD XR system.Results LC condition:Knietex 100×2.1mm,2.6μm as the column,the mobile phase was fluoride(NH4F)in water(buffer A)and methanol(buffer B).The analysis of uE3 was accomplished within 8min.MS condition:the samples were analyzed by ID-LC-MS/MS system in the negativelyelectro-spray ioniz ation(ESI)mode and multiple reaction monitor(MRM)mode.And the MRM transitions used for each analytes were:(m/z)287→145(quantitative)and m/z 287→171(qualitative)for uE3,m/z 290→148(quantitative)and m/z 290→174(qualitative)for internal standard.Extraction:n-Hexane/ethyl acetate(50∶50,v/v)was chosen to the extraction solvent,and the volume ratio of the serum sample to extraction solvent was 1∶2.The mean extraction efficiency for the method was determined to be 85.71% .Conclusion This study successfully optimized the LC and MS conditions and the ideal condition was obtained of the determination of uE3 in human serum using ID-LC-MS/MS.The applicable extract method was determined.This study was an important base of establish the candidate reference measurement procedure for the determination of uE3 in human serum using ID-LC-MS/MS.
出处 《检验医学与临床》 CAS 2015年第10期1347-1349,共3页 Laboratory Medicine and Clinic
基金 科技部重大新药创制子项目(2012ZX09303009-003)
关键词 雌三醇 高效液相色谱 串联质谱 estriol high performance liquid chromatography tandem mass spectrometry
  • 相关文献

参考文献13

  • 1Bestwick JP, Huttly WJ, Wald NJ. Uneonjugated estriol values between 14 and 22 weeks of gestation in relation to prenatal screening for Down syndrome[J]. Prenat Diagn,2012,32(3):299-301.
  • 2Huang X, Spink DC, Schneider E, et al. Measurement of uneonjugated estriol in serum by liquid chromatography- tandem mass spectrometry and assessment of the accuracy of chemiluminescent immunoassays[J]. Clin Chem, 2014, 60(1) :260-268.
  • 3Olsen RN, Dunsmoor-Su R, Capurro D, et al. Correlation between spontaneous preterm birth and mid-trimester maternal serum estriol[J]. J Matern Fetal Neonatal Med, 2014,27(4) :376-380.
  • 4Faupel-Badger JM, Fuhrman BJ, Xu X, et al. Comparison of liquid chromatography-tandem mass spectrometry, RIA,and ELISA methods for measurement of urinary es trogens[J]. Cancer Epidemiol Biomarkers Prey, 2010, 19 (1) :292-300.
  • 5Wolford ST,Argoudelis CJ. Measurement of estrogens in cowrs milk, human milk, and dairy products[J]. J Dairy Sci, 1979,62(9) : 1458-1463.
  • 6Weissbach A, Freymann E, Hubl W, et al. Enzymeimmu- noassay of unconjugated estriol in serum and saliva during pregnancy[J]. Exp Clin Endocrinol, 1985, 86 (2): 178- 184.
  • 7Ghosh M, Dhar TK, Ali E, et al. Homogeneous enzyme immunoassay of estriol in pictogram amounts[J]. Clin Chim Acta, 1983,128 (2/3) : 223-231.
  • 8Benn PA, Makowski GS, Egan JF, et al. Reproducibility of risk figures in 2nd-trimester maternal serum screening for down syndrome: comparison of 2 laboratories [J]. Clin Chem, 2006,52(11) : 2087-2094.
  • 9韩丽乔,庄俊华,黄宪章.质谱技术及其在临床检验中的应用[J].检验医学,2013,28(3):252-256. 被引量:14
  • 10Gust M, Vulliet E, Giroud B, et al. Development, valida- tion and comparison of LC-MS/MS and RIA methods for quantification of vertebrates-like sex-steroids in proso- branchmolluscs[J]. J Chromatogr B, 2010,878 (19) : 1487- 1492.

二级参考文献31

  • 1胡晓舟,张捷.医学检验中液相色谱-串联质谱的应用[J].临床检验杂志,2005,23(4):314-316. 被引量:7
  • 2Burtis CA,Ashwood ER, Bruns DE. Tietz textbook of clinical chemistry and molecular diagnosis [ M ]. 4th edition. St. Louis : Elsevier Inc ,2006 : 128-137.
  • 3Kikuchi K, Enari T, Totsuka K, et al. Comparison of phenotypic characteristics, DNA-DNA hybridization results, and results with a commercial rapid bio- chemical and enzymatic reaction system for identifica- tion of viridians group Streptococci [ J ]. J Clin Microbiol, 1995,33 ( 5 ) : 1215-1222.
  • 4Rajakaruna L, Hallas G, Molenaar L, et al. High throughput identification of clinical isolates of Staphy- lococcus aureus using MALDI-TOF-MS of intact cells [ J ]. Infect Genet Evol, 2009,9 (4) : 507 -513.
  • 5Pinto A, Halliday C, Zahra M, et al. Matrix-assisted laser desorption ionization-time of flight mass spectrometry identification of yeasts is contingent on robust reference spectra [ J ]. PLoS One, 2011, 6 (10) :e25712.
  • 6Bader O, Weig M,Taverne-Ghadwal L,et al. Improved clinical laboratory identification of human pathogenic yeasts by matrix-assisted laser desorption ionization time-of-flight mass spectrometry [ J ]. Clin Microbiol Infect,2011,17 (9) : 1359-1365.
  • 7Liu C, Pan C, Shen J, et al. MALDI-TOF MS combined with magnetic beads for detecting serum protein bio- markers and establishment of boosting decision tree model for diagnosis of colorectal cancer[ J]. Int J Ned Sei,2011,8(1) :39-47.
  • 8Ummanni R, Mundt F, Pospisil H, et al. Identification of clinically relevant protein targets in prostate cancer with 2D-DIGE coupled mass spectrometry and sys- tems biology network platform[ J]. PLoS One,2011, 6(2) :e16833.
  • 9Matta A,Ralhan R, DeSouza LV, et al. Mass spectrom- etry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery [ J ]. Mass Spectrom Rev, 2010,29 ( 6 ) : 945-961.
  • 10Benkali K, Marquet P,Rerolle J,et al. A new strategy for faster urinary biomarkers identification by Nano- LC-MALDI-TOF/TOF mass spectrometry [ J ]. BMC Genomics, 2008,9 : 541.

共引文献13

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部